Disclaimer

The information contained in this section of Physitrack's website contains information relating to an offering to the general public in Sweden and Finland from Physitrack PLC (the "Company") to subscribe for shares in connection with the admission to trading of the shares on Nasdaq First North Premier Growth Market in Stockholm. This information may not be accessed by residents of certain countries based on applicable securities law regulations.

NOT FOR DISTRIBUTION, DIRECTLY OR INDIRECTLY, WHOLLY OR PARTLY, IN THE UNITED STATES OF AMERICA (INCLUDING ITS TERRITORIES AND POSSESSIONS), ANY STATE OF THE UNITED STATES INCLUDING THE DISTRICT OF COLUMBIA, AUSTRALIA, CANADA, HONG KONG, JAPAN, NEW ZEALAND, SINGAPORE, SWITZERLAND, SOUTH AFRICA, SOUTH KOREA OR ANYOTHER JURISDICTION WHERE TO DO SO WOULD BE PROHIBITED BY APPLICABLE LAW.

This website and the information contained herein is not intended for, and may not be accessed by, or distributed or disseminated to, persons resident or physically present in the United States of America (including its territories and possessions), any state of the United States including the District of Columbia (the "United States"), Australia, Canada, Hong Kong,Japan, New Zealand, Singapore, Switzerland, South Africa, South Korea and do not constitute an offer to sell or the solicitation of an offer to purchase or acquire, any shares in the Company in any of the above mentioned jurisdictions or in any other jurisdiction in which such offer or solicitation would be unlawful prior to registration or qualification under the securities laws of such jurisdiction. The shares in the Company referred to on this website have not been, and will not be, registered under the Securities Act of 1933, as amended(the "Securities Act"), and may not be offered or sold in the United States absent registration or an exemption from registration under the Securities Act.

All persons residing outside of the above-mentioned jurisdictions who wish to access the documents contained on this website should first ensure that they are not subject to local laws or regulations that prohibit or restrict their right to access this website, or require registration or approval for any acquisition of securities by them. The Company nor the Joint Global Coordinator assumes no responsibility if there is a violation of applicable law and regulations by any person.

If you are not permitted to view materials on this website or are in any doubt as to whether you are permitted to view these materials, please exit this website.

Access to electronic versions of these materials is being made available on this website by the Physitrack in good faith and for information purposes only.

By clicking "Confirm" you confirm and certify that:

  • You are not a resident of or physically present in any of the above jurisdictions or any other restricted jurisdiction and are not a U.S. person (as defined inRegulation S under the Securities Act); and
  • you are either:

(a)  a resident of, or physically present in Sweden or Finland;

(b) if resident or physically present in a Member State of the European Economic Area other than Sweden or Finland, a qualified investor as defined in Regulation (EU)2017/1129 of the European parliament and of the council; or

(c) otherwise authorised to access this information pursuant to applicable laws or regulations.

Physitrack has announced an offering of shares in connection with listing on Nasdaq First North Premier Growth Market in Stockholm

  • The price per share in the Offering is SEK 40, corresponding to a total value of all the outstanding shares in Physitrack of approximately SEK 624 million upon completion of the Offering.
  • The Offering consists of up to 4,375,000 newly issued shares, corresponding to a total value of up to SEK 175 million, excluding any over-allotment option (as described in the Prospectus)
  • Consensus Asset Management (through the funds Consensus Småbolag and Consensus Sverige Select) and Atlant Fonder have undertaken, under certain conditions, and at the same offering price as other investors, to subscribe for shares corresponding to a total value of SEK 125 million. The undertakings represent, in aggregate, 20 percent of the outstanding shares in the Company upon completion of the Offering and approximately 71 percent of the number of shares in the Offering (approximately 62 percent assuming the Over-Allotment Option is exercised in full).
  • The Offering will be offered to the general public in Sweden and Finland and to institutional investors in Sweden and abroad.

Time plan

  • Application period for the public: 9 June - 16 June 2021
  • Application period for institutional investors: 9 June - 17 June 2021
  • First day of trading on Nasdaq First North Growth Market Premier: 18 June 2021
  • Settlement: 22 June 2021

Please see the Prospectus for more information.

Outcome of offering press release (18 June 2021)